La Touche Roy, Paris-Alemany Alba, Pardo-Montero Joaquín, Miñambres-Martín Diego, Mercado-Romero Francisco, de la Rosa-Díaz Irene, Sorrel Miguel A, Grande-Alonso Mónica
Departamento de Fisioterapia, Centro Superior de Estudios Universitarios (CSEU) La Salle, Universidad Autónoma de Madrid, Madrid, Spain.
Motion in Brains Research Group, Institute of Neuroscience and Sciences of the Movement (INCIMOV), Centro Superior de Estudios Universitarios La Salle, Madrid, Spain.
Front Med (Lausanne). 2024 May 9;11:1358829. doi: 10.3389/fmed.2024.1358829. eCollection 2024.
The purpose of this research was to design and psychometrically validate a new instrument (the Biobehavioural Pain and Movement Questionnaire/BioPMovQ), which assesses the relationship between pain and various factors related to motor behaviour from a biobehavioural perspective.
A mixed-method design combining a qualitative study with an observational and cross-sectional study was employed to develop (content validity) and psychometrically validate (construct validity, reliability and concurrent/discriminant validity) a new instrument. A total of 200 patients with chronic musculoskeletal pain were recruited.
According to the exploratory factor analysis, the final version of the BioPMovQ consists of 16 items distributed across 4 subscales (1, disability, 2, self-efficacy for physical activity; 3, movement avoidance behaviours; and 4, self-perceived functional ability), all with an eigen value greater than 1, explaining 55.79% of the variance. The BioPMovQ showed high internal consistency (Cronbach's = 0.82; McDonald's = 0.83). The intraclass correlation coefficient was 0.86 (95% confidence interval 0.76 to 0.91), which was considered to demonstrate excellent test-retest reliability. The standard error of measurement and minimal detectable change were 3.43 and 8.04 points, respectively. No floor or ceiling effects were identified. There was a positive, significant and moderate magnitude correlation with the Graded Chronic Pain Scale ( = 0.54), kinesiophobia ( = 0.60), pain catastrophising ( = 0.44) and chronic pain self-efficacy ( = -0.31).
The BioPMovQ showed good psychometric properties. Based on the findings of this study, the BioPMovQ can be used in research and clinical practice to assess patients with chronic musculoskeletal pain.
本研究旨在设计并从心理测量学角度验证一种新的工具(生物行为疼痛与运动问卷/BioPMovQ),该问卷从生物行为学角度评估疼痛与各种运动行为相关因素之间的关系。
采用定性研究与观察性及横断面研究相结合的混合方法设计来开发(内容效度)并从心理测量学角度验证(结构效度、信度和同时/区分效度)一种新工具。共招募了200名慢性肌肉骨骼疼痛患者。
根据探索性因素分析,BioPMovQ的最终版本由16个项目组成,分布在4个子量表中(1,残疾;2,身体活动自我效能;3,运动回避行为;4,自我感知功能能力),所有项目的特征值均大于1,解释了55.79%的方差。BioPMovQ显示出较高的内部一致性(Cronbach's α = 0.82;McDonald's ω = 0.83)。组内相关系数为0.86(95%置信区间0.76至0.91),被认为具有出色的重测信度。测量标准误和最小可检测变化分别为3.43分和8.04分。未发现地板效应或天花板效应。与分级慢性疼痛量表(r = 0.54)、运动恐惧(r = 0.60)、疼痛灾难化(r = 0.44)和慢性疼痛自我效能(r = -0.31)呈正相关、显著且中等程度相关。
BioPMovQ显示出良好的心理测量学特性。基于本研究结果,BioPMovQ可用于研究和临床实践中评估慢性肌肉骨骼疼痛患者。